189 related articles for article (PubMed ID: 17038824)
1. Mechanism of adsorption of three recombinant Streptococcus pneumoniae (Sp) vaccine antigens by an aluminum adjuvant.
Levesque PM; de Alwis U
Hum Vaccin; 2005; 1(2):70-3. PubMed ID: 17038824
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of adsorption of hepatitis B surface antigen by aluminum hydroxide adjuvant.
Iyer S; Robinett RS; HogenEsch H; Hem SL
Vaccine; 2004 Mar; 22(11-12):1475-9. PubMed ID: 15063571
[TBL] [Abstract][Full Text] [Related]
3. Preformulation characterization of an aluminum salt-adjuvanted trivalent recombinant protein-based vaccine candidate against Streptococcus pneumoniae.
Iyer V; Hu L; Liyanage MR; Esfandiary R; Reinisch C; Meinke A; Maisonneuve J; Volkin DB; Joshi SB; Middaugh CR
J Pharm Sci; 2012 Sep; 101(9):3078-90. PubMed ID: 22538529
[TBL] [Abstract][Full Text] [Related]
4. Formulation of botulinum neurotoxin heavy chain fragments for vaccine development: mechanisms of adsorption to an aluminum-containing adjuvant.
DePaz RA; Henderson I; Advant SJ
Vaccine; 2005 Jul; 23(31):4029-35. PubMed ID: 15963360
[TBL] [Abstract][Full Text] [Related]
5. Role of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro.
Morefield GL; Sokolovska A; Jiang D; HogenEsch H; Robinson JP; Hem SL
Vaccine; 2005 Feb; 23(13):1588-95. PubMed ID: 15694511
[TBL] [Abstract][Full Text] [Related]
6. The importance of surface charge in the optimization of antigen-adjuvant interactions.
Callahan PM; Shorter AL; Hem SL
Pharm Res; 1991 Jul; 8(7):851-8. PubMed ID: 1924135
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the compatibility of a second generation recombinant anthrax vaccine with aluminum-containing adjuvants.
Jendrek S; Little SF; Hem S; Mitra G; Giardina S
Vaccine; 2003 Jun; 21(21-22):3011-8. PubMed ID: 12798645
[TBL] [Abstract][Full Text] [Related]
8. Relationship between the strength of antigen adsorption to an aluminum-containing adjuvant and the immune response.
Hansen B; Sokolovska A; HogenEsch H; Hem SL
Vaccine; 2007 Sep; 25(36):6618-24. PubMed ID: 17681647
[TBL] [Abstract][Full Text] [Related]
9. Effect of the degree of phosphate substitution in aluminum hydroxide adjuvant on the adsorption of phosphorylated proteins.
Iyer S; HogenEsch H; Hem SL
Pharm Dev Technol; 2003; 8(1):81-6. PubMed ID: 12665200
[TBL] [Abstract][Full Text] [Related]
10. Quantitative Analysis of Vaccine Antigen Adsorption to Aluminum Adjuvant Using an Automated High-Throughput Method.
Ahl PL; Wang SC; Chintala R; Mensch C; Smith WJ; Wenger M; Blue J
PDA J Pharm Sci Technol; 2018; 72(2):149-162. PubMed ID: 29343619
[TBL] [Abstract][Full Text] [Related]
11. Factors affecting alum-protein interactions.
Huang M; Wang W
Int J Pharm; 2014 May; 466(1-2):139-46. PubMed ID: 24607202
[TBL] [Abstract][Full Text] [Related]
12. Relationship between tightness of binding and immunogenicity in an aluminum-containing adjuvant-adsorbed hepatitis B vaccine.
Egan PM; Belfast MT; Giménez JA; Sitrin RD; Mancinelli RJ
Vaccine; 2009 May; 27(24):3175-80. PubMed ID: 19446188
[TBL] [Abstract][Full Text] [Related]
13. The in vitro displacement of adsorbed model antigens from aluminium-containing adjuvants by interstitial proteins.
Heimlich JM; Regnier FE; White JL; Hem SL
Vaccine; 1999 Jul; 17(22):2873-81. PubMed ID: 10438058
[TBL] [Abstract][Full Text] [Related]
14. Association between immunogenicity and adsorption of a recombinant Streptococcus pneumoniae vaccine antigen by an aluminum adjuvant.
Levesque PM; Foster K; de Alwis U
Hum Vaccin; 2006; 2(2):74-7. PubMed ID: 17012880
[TBL] [Abstract][Full Text] [Related]
15. Change in the degree of adsorption of proteins by aluminum-containing adjuvants following exposure to interstitial fluid: freshly prepared and aged model vaccines.
Shi Y; HogenEsch H; Hem SL
Vaccine; 2001 Oct; 20(1-2):80-5. PubMed ID: 11567749
[TBL] [Abstract][Full Text] [Related]
16. Contribution of electrostatic and hydrophobic interactions to the adsorption of proteins by aluminium-containing adjuvants.
al-Shakhshir RH; Regnier FE; White JL; Hem SL
Vaccine; 1995 Jan; 13(1):41-4. PubMed ID: 7762276
[TBL] [Abstract][Full Text] [Related]
17. Stability of aluminium-containing adjuvants during aging at room temperature.
Burrell LS; White JL; Hem SL
Vaccine; 2000 Apr; 18(21):2188-92. PubMed ID: 10717337
[TBL] [Abstract][Full Text] [Related]
18. Effect of protein adsorption on the surface charge characteristics of aluminium-containing adjuvants.
al-Shakhshir R; Regnier F; White JL; Hem SL
Vaccine; 1994 Apr; 12(5):472-4. PubMed ID: 8023556
[TBL] [Abstract][Full Text] [Related]
19. Effect of the strength of adsorption of hepatitis B surface antigen to aluminum hydroxide adjuvant on the immune response.
Hansen B; Belfast M; Soung G; Song L; Egan PM; Capen R; Hogenesch H; Mancinelli R; Hem SL
Vaccine; 2009 Feb; 27(6):888-92. PubMed ID: 19071182
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of Antigen Adsorption Onto an Aluminum-Hydroxide Adjuvant Evaluated by High-Throughput Screening.
Jully V; Mathot F; Moniotte N; Préat V; Lemoine D
J Pharm Sci; 2016 Jun; 105(6):1829-1836. PubMed ID: 27238481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
